Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261975017
Mayo Foundation
Search grants from Mayo Foundation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Coordinating Center: Molecular and Cellular Findings of Screen-Detected Lesions
Phenomenology/Neurophysiology Of Juvenile Bipolar Dis
Nanosecond & Picosecond Transient Spectroscopy
Multifocal Cerebral Ischemia
SV40 Antigen, Chromatin Structure and Viral Function
Recently added grants:
Core C: GAGomics and Proteomics
Project 1: Megakaryocytes as Organizers of the Hematopoietic Environment
Project 2: Extracellular Glycosylation and Blood Cell Production
Project 3: Role of Glycosaminoglycans in Hematopoiesis
Cancer Center Support Grant
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA075017-006
Application #
6828776
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Mayo Foundation
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261075017
/ Mayo Foundation
NIH 2003
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261975017
/ Mayo Foundation
Comments
Be the first to comment on this grant